CING READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ:CING) reported 2024 results on March 26th, 2025. No revenues ...

April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

Cingulate (CING) has received a $3M grant to accelerate the development of CTx-2103 for the treatment of anxiety. CTx-2103 has the potential to ...

Cingulate (NASDAQ:CING – Get Free Report) is projected to announce its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($1.48) per ...

Cingulate (CING) announced that it held a Pre-NDA meeting with the U.S. Food and Drug Administration, FDA, yesterday to discuss the submission ...

Explore Cingulate stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CING. EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...